Characterization of AB598, a CD39 Enzymatic Inhibitory Antibody for the Treatment of Solid Tumors.
Anderson AE, Parashar K, Jin K, Clor J, Stagnaro CE, Vani U, Singh J, Chen A, Guan Y, Talukdar P, Sathishkumar P, Juat DJ, Singh H, Kushwaha R, Zhao X, Kaplan A, Seitz L, Walters MJ, Fernandez-Salas E, Walker NPC, Bowman CE.
Anderson AE, et al.
Mol Cancer Ther. 2024 Oct 1;23(10):1471-1482. doi: 10.1158/1535-7163.MCT-23-0865.
Mol Cancer Ther. 2024.
PMID: 38797955
Free PMC article.